Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
biotech
life sciences
national blog main
san francisco
san francisco blog main
4
×
san francisco top stories
startups
alphabet
clinical trials
fda
google
biological drugs
boston blog main
drug delivery
drugs
gv
insulin
investing
medical device
mir imran
novartis
octreotide
rani therapeutics
roboticsai
shire
takeda pharmaceutical
ame cloud ventures
american association for cancer research astrazeneca
american diabetes association
astrazeneca
boston top stories
broad institute of harvard and mit
brook byers
charles chu
clostridium difficile
colleen cutcliffe
computational biology
crispr
crispr cas14
deals
What
available
4
×
biological
biologics
can’t
cells
clears
convenience
digestive
drugs
enzymes
humans
hurdle
pill
proteins
rani’s
robotic
survive
swallowing
that’s
therapies
today
balance
based
big
bio
biome
biosciences
blood
cas
cheaper
crispr
develop
diabetes
diagnostics
expects
eyes
faster
food
healthy
hormone
Language
unset
Current search:
available
×
photo
×
" san francisco blog main "
×
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
4 years ago
With $35M, Whole Biome Eyes 2020 Launch of Medical Food for Diabetes
@xconomy.com
5 years ago
Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans
@xconomy.com
5 years ago
Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans